Immunocore Holdings plc reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was GBP 51.49 million compared to GBP 41.2 million a year ago. Net income was GBP 1.9 million compared to GBP 6.23 million a year ago. Basic earnings per share from continuing operations was GBP 0.04 compared to GBP 0.13 a year ago. Diluted earnings per share from continuing operations was GBP 0.04 compared to GBP 0.12 a year ago.
For the nine months, revenue was GBP 143.79 million compared to GBP 95.68 million a year ago. Net loss was GBP 28.87 million compared to GBP 16.02 million a year ago. Basic loss per share from continuing operations was GBP 0.59 compared to GBP 0.36 a year ago. Diluted loss per share from continuing operations was GBP 0.59 compared to GBP 0.36 a year ago.